Latest GHIAA News

GHIAA & MAPGuide updates

  • MAPGuide Featured in New "Inventory of COVID-19 Information Resources" (March 31, 2022) - Compiled by the World Trade Organization, this resource provides information on a variety of topics, such as vaccination, production of vaccines, government procurement, cases, diagnostics, therapeutics and intellectual property-related issues from NGOs, IGOS, academics, nonprofits, and the private sector. The inventory will be updated as new resources become available. Access the Inventory
  • GHIAA Participates in Vaccine Equity Conference with Columbia University (March 18, 2022) - On Wednesday, March 30 at 12pm EST, GHIAA Executive Director Julie Barnes-Weise will participate in a roundtable discussion titled "Vaccine Equity Distribution Capacity-Building in terms of IP, Technology and Talent Transfer, and Manufacturing." The roundtable is part of a 4-day symposium on Covid-19 vaccines hosted by the Columbia University Irving Medical Center. This symposium is free and virtual, with registration required. Register Here
  • Panel Participation (February 25, 2022) - The global intellectual property framework has been instrumental to developing Covid vaccines, with billions of doses now made every month. Following our recent paper assessing the proposed intellectual property waiver as a mechanism to address COVID-19 vaccine scarcity, GHIAA Executive Director, Julie Barnes-Weise will participate in a panel hosted by the Geneva Network on March 2. Register Here
  • Upcoming Joint Webinar with WTO, WIPO, and WHO (February 20, 2022) - On February 28, 2022, GHIAA Executive Director Julia Barnes-Weise will be discussing the MAPGuide as part of a virtual workshop on COVID-19 related information resources. This is the second in a series of workshops aimed at strengthening the capacity of policymakers across the WTO, WIPO, and WHO. Register Here
  • New Commentary in The Journal of Epidemiology & Community Health (February 13, 2022) - The idea for temporary IP waivers to facilitate the development of urgently-needed vaccines has gained recent traction in the global health world. In our latest commentary for the Journal of Epidemiology and Community Health, authors Julia Barnes-Weise, Ana Santos Rutschman, and Reid Adler discuss why IP waivers are an imperfect solution to the supply problem- and what should be improved upon instead. Read Article
  • Jaharis Law Presentation (April 30, 2021) - GHIAA Executive Director Julie Barnes-Wise spoke at the Mary and Michael Jaharis Health Law Institute Annual Symposium on Thursday April 29th, 2021. Her presentation discussed the role of step-in rights and technology transfer in relation to equitable access to vaccinations amidst the COVID-19 pandemic. Read More
  • STAT article: the need for the MAPGuide (April 1, 2021) - Global healthcare partners will benefit from a shareable repository of contracts to address key issues in global health research, development, and purchasing. A glossary informs stakeholders about alternate definitions of key terms to prepare parties for negotiations and to give them a common language for discussion. Read Article
  • Promoting Innovation Where Market Incentives Do Not Work (March 10, 2021) - Supporting the development of innovative health products is not only important in the fields of orphan drugs and neglected tropical diseases but also for pandemic preparedness. Our Executive Director, Julie Barnes-Weise, has contributed to this article about how such development can be supported and created an interesting chart setting out how public funding incentives are balanced by the concerns of different types of developers. This article was originally published by Licensing Executives Society International. Read Article
  • Katrine Thor Andersen Joins GHIAA’s Board of Directors (March 8, 2021) - The Global Health Innovation Alliance Accelerator (GHIAA) is pleased to announce the appointment of Katrine Thor Andersen to its Board of Directors. Read More
  • Glossary of Global Health Agreement Terms (December 1, 2020) - GHIAA is pleased to announce the publication of its Glossary of Global Health Agreement Terms - a curated collection of often used terms in policies, negotiations and agreements in the global public health field. Our continuing goal is to facilitate the discussions which lead to successful global health transactions and alliances. GHIAA welcomes suggestions of new terms and definitions which are important to the global health policy and transactions community. Read More
  • New grant from the Wellcome Trust (August 25, 2020) - We are pleased to announce a new grant from the Wellcome Trust to support further development of the MAPGuide. Read More
  • Launch of the MAPGuide (August 11, 2020) - The GHIAA MAPGuide is now available for public use. We look forward to receiving user feedback as well as additional agreements and provisions to include in the MAPGuide. Read More
  • COVID-19 agreements (August 10, 2020) - GHIAA is tracking new agreements arising from the development of COVID-19 diagnostics, therapeutics and vaccines with the aim of including COVID-19 agreements in the MAPGuide. GHIAA also recently provided input to an article published in Science on the importance of knowledge transfer for large-scale vaccine manufacturing in the context of COVID-19. See COVID-19 Agreements in the MAPGuide.
  • Wellcome Trust grant (November 18, 2019) - GHIAA is excited to announce that it is receiving support from the Wellcome Trust to further develop its online Master Alliance Provisions Guide (MAPGuide), accelerating the introduction of life-saving global health technologies by streamlining the formation of research and development alliances. Read More